JP2017537380A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537380A5
JP2017537380A5 JP2017522100A JP2017522100A JP2017537380A5 JP 2017537380 A5 JP2017537380 A5 JP 2017537380A5 JP 2017522100 A JP2017522100 A JP 2017522100A JP 2017522100 A JP2017522100 A JP 2017522100A JP 2017537380 A5 JP2017537380 A5 JP 2017537380A5
Authority
JP
Japan
Prior art keywords
distribution
scores
gene
disease
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017522100A
Other languages
English (en)
Japanese (ja)
Other versions
JP6707081B2 (ja
JP2017537380A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/056646 external-priority patent/WO2016064995A1/en
Publication of JP2017537380A publication Critical patent/JP2017537380A/ja
Publication of JP2017537380A5 publication Critical patent/JP2017537380A5/ja
Application granted granted Critical
Publication of JP6707081B2 publication Critical patent/JP6707081B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017522100A 2014-10-22 2015-10-21 正の選択下で遺伝子を同定する方法 Expired - Fee Related JP6707081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462067294P 2014-10-22 2014-10-22
US62/067,294 2014-10-22
PCT/US2015/056646 WO2016064995A1 (en) 2014-10-22 2015-10-21 Method to identify genes under positive selection

Publications (3)

Publication Number Publication Date
JP2017537380A JP2017537380A (ja) 2017-12-14
JP2017537380A5 true JP2017537380A5 (https=) 2018-11-29
JP6707081B2 JP6707081B2 (ja) 2020-06-10

Family

ID=54541186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017522100A Expired - Fee Related JP6707081B2 (ja) 2014-10-22 2015-10-21 正の選択下で遺伝子を同定する方法

Country Status (6)

Country Link
US (1) US10886005B2 (https=)
EP (1) EP3210141A1 (https=)
JP (1) JP6707081B2 (https=)
AU (1) AU2015336005B2 (https=)
CA (1) CA2965163A1 (https=)
WO (1) WO2016064995A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6707081B2 (ja) 2014-10-22 2020-06-10 ベイラー カレッジ オブ メディスンBaylor College Of Medicine 正の選択下で遺伝子を同定する方法
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
US12071669B2 (en) 2016-02-12 2024-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for detection of abnormal karyotypes
US11281977B2 (en) * 2017-07-31 2022-03-22 Cognizant Technology Solutions U.S. Corporation Training and control system for evolving solutions to data-intensive problems using epigenetic enabled individuals
CN110782947A (zh) * 2019-10-18 2020-02-11 湖南大学 基于蛋白质序列功能区域的癌症驱动识别
WO2021178952A1 (en) * 2020-03-06 2021-09-10 The Research Institute At Nationwide Children's Hospital Genome dashboard
CN113643754B (zh) * 2021-08-11 2023-12-29 苏州赛美科基因科技有限公司 一种错义变异基因的评分处理方法、优化评分方法及装置
CN116897723A (zh) * 2022-08-01 2023-10-20 中国农业科学院都市农业研究所 一种基于植物感光基因调节的光源排列系统及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016860A2 (en) 1999-08-27 2001-03-08 Iris Bio Technologies, Inc. Artificial intelligence system for genetic analysis
US20040023296A1 (en) 2001-11-28 2004-02-05 Baylor College Of Medicine Use of quantitative evolutionary trace analysis to determine functional residues
KR101325736B1 (ko) * 2010-10-27 2013-11-08 삼성에스디에스 주식회사 바이오 마커 추출 장치 및 방법
WO2014007863A1 (en) 2012-07-03 2014-01-09 Baylor College Of Medicine Biological action of missense genotype perturbations on phenotype
JP6707081B2 (ja) 2014-10-22 2020-06-10 ベイラー カレッジ オブ メディスンBaylor College Of Medicine 正の選択下で遺伝子を同定する方法

Similar Documents

Publication Publication Date Title
JP2017537380A5 (https=)
Pomerantz et al. The association between germline BRCA2 variants and sensitivity to platinum‐based chemotherapy among men with metastatic prostate cancer
Yauy et al. Accurate detection of clinically relevant uniparental disomy from exome sequencing data
Moncunill et al. Comprehensive characterization of complex structural variations in cancer by directly comparing genome sequence reads
Williams et al. Identification of neutral tumor evolution across cancer types
Kim et al. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families
KR102028375B1 (ko) 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법
Uricchio et al. Selection and explosive growth alter genetic architecture and hamper the detection of causal rare variants
IL320112A (en) Methods and processes for non-invasive assessment of genetic variations
Juul et al. Non-coding cancer driver candidates identified with a sample-and position-specific model of the somatic mutation rate
KR102858552B1 (ko) 표적화 핵산 서열 분석 데이터를 정렬하는 방법
KR101949286B1 (ko) 암 환자의 유전체 염기서열 변이 정보와 생존 정보를 이용한 맞춤형 약물 선택 방법 및 시스템
CN112365922B (zh) 用于检测msi的微卫星位点、其筛选方法及应用
EP3841583A1 (en) Sensitively detecting copy number variations (cnvs) from circulating cell-free nucleic acid
Knevel et al. A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis
WO2020244538A1 (zh) 致病性单亲二倍体的筛查方法及应用
KR20220011630A (ko) 미소부수체 분석을 위한 방법 및 시스템
JP5789720B2 (ja) 遺伝子変異分析装置、遺伝子変異分析システム及び遺伝子変異分析方法
Baker et al. Silico: a simulator of long read sequencing in PacBio and Oxford Nanopore
CN113853444A (zh) 癌症患者生存率的预测方法
WO2017218798A1 (en) Systems and methods for diagnosing familial hypercholesterolemia
Brand et al. Resurrecting the alternative splicing landscape of archaic hominins using machine learning
Zhang et al. GPOPSIM: a simulation tool for whole-genome genetic data
Watson et al. Evolutionary dynamics in the decades preceding acute myeloid leukaemia
Cheng et al. Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer